Access to anti-retroviral drugs, female in Bahrain
Bahrain: Access to anti-retroviral drugs, female was 73.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Bahrain, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Bahrain is 73.0%, measured in 2024.
That represents a change of up 5.8% on the previous year and up 55.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Bahrain peaked at 98.0% in 2020 and was at its lowest, 12.0%, in 2000.
Bahrain ranks 71st of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Bahrain, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 12.0% | — |
| 2001 | 14.0% | +16.7% |
| 2002 | 24.0% | +71.4% |
| 2003 | 24.0% | +0.0% |
| 2004 | 23.0% | -4.2% |
| 2005 | 28.0% | +21.7% |
| 2006 | 31.0% | +10.7% |
| 2007 | 30.0% | -3.2% |
| 2008 | 31.0% | +3.3% |
| 2009 | 34.0% | +9.7% |
| 2010 | 37.0% | +8.8% |
| 2011 | 41.0% | +10.8% |
| 2012 | 47.0% | +14.6% |
| 2013 | 47.0% | +0.0% |
| 2014 | 47.0% | +0.0% |
| 2015 | 53.0% | +12.8% |
| 2016 | 53.0% | +0.0% |
| 2017 | 69.0% | +30.2% |
| 2018 | 77.0% | +11.6% |
| 2019 | 95.0% | +23.4% |
| 2020 | 98.0% | +3.2% |
| 2021 | 67.0% | -31.6% |
| 2022 | 62.0% | -7.5% |
| 2023 | 69.0% | +11.3% |
| 2024 | 73.0% | +5.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 25.1% | 12.0% | 34.0% | 10 |
| 2010s | 56.6% | 37.0% | 95.0% | 10 |
| 2020s | 73.8% | 62.0% | 98.0% | 5 |
Countries ranked near Bahrain
More gender data for Bahrain
- Child population (UN estimates and projections) 307.73 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.2195 % change on previous year (2030)
- Population 1,457 (2030)
- Working-age population (UN estimates and projections) 1,457 (2030)
- Population (UN estimates and projections), annual growth rate 1.23 % change on previous year (2030)
- Age population, age 00, female, interpolated 9,733 (2025)
- Age population, age 00, male, interpolated 10,092 (2025)
- Age population, age 01, female, interpolated 9,943 (2025)
- Age population, age 01, male, interpolated 10,248 (2025)
- Age population, age 02, female, interpolated 9,619 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Bahrain?
- Access to anti-retroviral drugs, female in Bahrain was 73.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Bahrain?
- The highest recorded value was 98.0% in 2020.
- What is the lowest access to anti-retroviral drugs, female recorded in Bahrain?
- The lowest recorded value was 12.0% in 2000.
- How does Bahrain rank for access to anti-retroviral drugs, female?
- Bahrain ranks 71st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Bahrain?
- Over the last ten years it is up 55.3%. The long-run trend across the full record is rising.
- Where does this Bahrain data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.